The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 25, 2020
Filed:
Mar. 17, 2016
Applicant:
Baylor Research Institute, Dallas, TX (US);
Inventors:
Ajay Goel, Dallas, TX (US);
Kunitoshi Shigeyasu, Dallas, TX (US);
Assignee:
Baylor Research Institute, Dallas, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); C12N 15/113 (2010.01); C12Q 1/6886 (2018.01); G01N 33/574 (2006.01); A61P 35/04 (2006.01); A61P 35/00 (2006.01); C07K 16/28 (2006.01); C07K 16/32 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1138 (2013.01); A61P 35/00 (2018.01); A61P 35/04 (2018.01); C07K 16/28 (2013.01); C07K 16/32 (2013.01); C12N 15/1135 (2013.01); C12Q 1/6886 (2013.01); G01N 33/57419 (2013.01); C12N 2310/11 (2013.01); C12N 2310/14 (2013.01); C12N 2310/531 (2013.01); C12Q 2600/158 (2013.01);
Abstract
Certain embodiments provide methods and compositions related to clinical management of cancer patients based on the expression level of TMCO3. Further embodiments involve methods and compositions related to treatment of cancer patients or patients determined to have an increased TMCO3 level relative to a control or a reference level that is normal or indicating favorable prognosis.